Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Hartmann

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Cancer Research|October 1, 1993
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomasM K Dodson, L C Hartmann, W A Cliby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Prognostic significance of p53 immunostaining in epithelial ovarian cancerL C Hartmann, K C Podratz, G L Keeney, et al.
Journal of the National Cancer Institute|August 2, 1989
Use of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patientsL C Hartmann, W J Urba, R G Steis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Journal of the National Cancer Institute|February 7, 1990
Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphomaL A VanderMolen, R G Steis, P L Duffey, et al.
Annals of Internal Medicine|June 20, 1998
Increased risk for cancer in patients with the Peutz-Jeghers syndromeL A Boardman, S N Thibodeau, D J Schaid, et al.
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Cancer|July 15, 1997
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinomaJ N Ingle, P A Johnson, V J Suman, et al.
Mayo Clinic Proceedings|June 1, 1994
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experienceT M Pisansky, M Y Halyard, A L Weaver, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2001
Cigarette smoking increases risk for breast cancer in high-risk breast cancer familiesF J Couch, J R Cerhan, R A Vierkant, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Cancer Research|October 1, 1993
Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomasM K Dodson, L C Hartmann, W A Cliby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Prognostic significance of p53 immunostaining in epithelial ovarian cancerL C Hartmann, K C Podratz, G L Keeney, et al.
Journal of the National Cancer Institute|August 2, 1989
Use of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patientsL C Hartmann, W J Urba, R G Steis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Journal of the National Cancer Institute|February 7, 1990
Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphomaL A VanderMolen, R G Steis, P L Duffey, et al.
Annals of Internal Medicine|June 20, 1998
Increased risk for cancer in patients with the Peutz-Jeghers syndromeL A Boardman, S N Thibodeau, D J Schaid, et al.
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Cancer|July 15, 1997
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinomaJ N Ingle, P A Johnson, V J Suman, et al.
Mayo Clinic Proceedings|June 1, 1994
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experienceT M Pisansky, M Y Halyard, A L Weaver, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2001
Cigarette smoking increases risk for breast cancer in high-risk breast cancer familiesF J Couch, J R Cerhan, R A Vierkant, et al.
Pageof 7